Cargando…
The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes
PURPOSE: To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. METHOD: Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their sta...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747869/ https://www.ncbi.nlm.nih.gov/pubmed/31555067 http://dx.doi.org/10.1177/1559325819876766 |
_version_ | 1783451994518716416 |
---|---|
author | Li, Shang-Yi Chen, Hsin-Hung Lin, Cheng-Li Yeh, Su-Yin Kao, Chia-Hung |
author_facet | Li, Shang-Yi Chen, Hsin-Hung Lin, Cheng-Li Yeh, Su-Yin Kao, Chia-Hung |
author_sort | Li, Shang-Yi |
collection | PubMed |
description | PURPOSE: To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. METHOD: Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their statin use, namely hydrophilic statin and lipophilic statin. We used Cox proportional hazard regression models to analyze the risks of cardiovascular outcomes. RESULT: In this study, 12 896 patients used statin, including 4259 patients using hydrophilic statin and 8637 patients using lipophilic statin. With 12-year follow-up, higher incidence rate of coronary artery disease and stroke was noted in the lipophilic statin use instead of hydrophilic statin use. CONCLUSION: According to our long-term cohort study, hydrophilic statin use may be a better choice than lipophilic statin to reduce cardiovascular events in Asian diabetic patients. |
format | Online Article Text |
id | pubmed-6747869 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-67478692019-09-25 The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes Li, Shang-Yi Chen, Hsin-Hung Lin, Cheng-Li Yeh, Su-Yin Kao, Chia-Hung Dose Response Original Article PURPOSE: To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. METHOD: Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their statin use, namely hydrophilic statin and lipophilic statin. We used Cox proportional hazard regression models to analyze the risks of cardiovascular outcomes. RESULT: In this study, 12 896 patients used statin, including 4259 patients using hydrophilic statin and 8637 patients using lipophilic statin. With 12-year follow-up, higher incidence rate of coronary artery disease and stroke was noted in the lipophilic statin use instead of hydrophilic statin use. CONCLUSION: According to our long-term cohort study, hydrophilic statin use may be a better choice than lipophilic statin to reduce cardiovascular events in Asian diabetic patients. SAGE Publications 2019-09-16 /pmc/articles/PMC6747869/ /pubmed/31555067 http://dx.doi.org/10.1177/1559325819876766 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Li, Shang-Yi Chen, Hsin-Hung Lin, Cheng-Li Yeh, Su-Yin Kao, Chia-Hung The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes |
title | The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes |
title_full | The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes |
title_fullStr | The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes |
title_full_unstemmed | The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes |
title_short | The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes |
title_sort | different cardiovascular outcomes between long-term efficacy of hydrophilic and lipophilic statin therapy in both asian diabetic sexes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747869/ https://www.ncbi.nlm.nih.gov/pubmed/31555067 http://dx.doi.org/10.1177/1559325819876766 |
work_keys_str_mv | AT lishangyi thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes AT chenhsinhung thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes AT linchengli thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes AT yehsuyin thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes AT kaochiahung thedifferentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes AT lishangyi differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes AT chenhsinhung differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes AT linchengli differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes AT yehsuyin differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes AT kaochiahung differentcardiovascularoutcomesbetweenlongtermefficacyofhydrophilicandlipophilicstatintherapyinbothasiandiabeticsexes |